Blueprint Medicines highlights ‘decade of leadership’ in Mast Cell research with new AYVAKIT and BLU-808 data at AAAAI/WAO 2025
“We are incredibly proud to showcase our mast cell therapy portfolio at AAAAI / WAO, with 14 presentations highlighting more than a decade of leadership and collaboration with… read more.